TENX Logo

Tenax Therapeutics, Inc. (TENX) 

NASDAQ
Market Cap
$21.21M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
390 of 968
Rank in Industry
236 of 556

Largest Insider Buys in Sector

TENX Stock Price History Chart

TENX Stock Performance

About Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial …

Insider Activity of Tenax Therapeutics, Inc.

Over the last 12 months, insiders at Tenax Therapeutics, Inc. have bought $12,498 and sold $0 worth of Tenax Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Tenax Therapeutics, Inc. have bought $373,101 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Davidson Michael H. (director) — $15,000. PROEHL GERALD T (director) — $14,994.

The last purchase of 2,500 shares for transaction amount of $7,500 was made by Davidson Michael H. (director) on 2024‑08‑08.

List of Insider Buy and Sell Transactions, Tenax Therapeutics, Inc.

2024-08-08Purchasedirector
2,500
0.1209%
$3.00$7,500-3.38%
2024-08-08Purchasedirector
1,666
0.0806%
$3.00$4,998-3.38%
2020-09-08Purchase
8,543
0.0707%
$1.46$12,473+29.93%
2020-09-04Purchase
23,457
0.181%
$1.41$33,074+25.85%
2020-09-03Purchase
36,000
0.2897%
$1.39$50,040+32.73%
2020-09-02Purchase
20,000
0.1666%
$1.47$29,400+29.93%
2020-09-01Purchase
30,000
0.2448%
$1.46$43,800+28.13%
2020-08-31Purchase
20,000
0.1632%
$1.45$29,000+29.02%
2020-08-27Purchase
12,000
0.0966%
$1.50$18,000+23.00%
2020-08-26Purchase10 percent owner
12,000
0.0959%
$1.50$18,000+22.19%
2020-08-25Purchase10 percent owner
17,211
0.1341%
$1.53$26,333+16.77%
2020-08-24Purchase10 percent owner
5,692
0.0468%
$1.47$8,367+28.13%
2020-08-21Purchase
116,242
0.8861%
$1.44$167,388+21.71%
2020-08-20Purchase
124,472
1.0016%
$1.53$190,442+20.59%
2020-08-19Purchase
70,767
0.5617%
$1.45$102,612+25.51%
2020-05-18Purchasedirector
5,000
0.0501%
$0.95$4,774+41.18%
2017-12-18Purchasedirector
12,950
0.0467%
$0.45$5,887-30.43%
2017-11-14Saledirector
12,950
0.0461%
$0.39$5,051-18.43%
2016-11-23Purchasedirector
14,449
0.0026%
$1.76$25,430-70.29%
2016-11-22Purchasedirector
15,433
0.0026%
$1.59$24,538-69.05%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.